Revisions of precautions for various drugs in Japan

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2007卷 / 1期

关键词：

D O I：

10.1007/s40278-024-58567-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：7 / 7

相关论文

共 50 条

[41] Revisions to the labeling of erectile dysfunction and diabetes drugs
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2008, 108 (02) : 79 - 79
[42] New precautions for technetium-based diagnostics in Japan
Reactions Weekly, 2015, 1564 (1) : 4 - 4
[43] Japan's PMDA revises precautions for multiple products
Reactions Weekly, 2017, 1661 (1) : 4 - 4
[44] JAPAN. Precautions against the spread of plague.
Gowey, John F.
PUBLIC HEALTH REPORTS, 1900, 15 (05) : 257 - 257
[45] Framework for controlling infection through isolation precautions in Japan
Kawakami, Kazumi
Misao, Hanako
NURSING & HEALTH SCIENCES, 2014, 16 (01) : 31 - 38
[46] Omeprazole and lansoprazole precautions have been strengthened in Japan
Reactions Weekly, 1998, 720 (1) : 5 - 5
[47] Precautions for amlodipine and nifedipine use in pregnancy updated in Japan
Reactions Weekly, 2023, 1946 (1) : 4 - 4
[48] More drugs now to include precautions against driving
Reactions Weekly, 2014, 1490 (1) : 2 - 2
[49] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
Shiragami, M
Nakai, K
DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
[50] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
Makoto Shiragami
Kiyohito Nakai
Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846

← 1 2 3 4 5 →